Your institution may have access to this item. Find your institution then sign in to continue.
Title
Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX.
Authors
Mazard, T.; Ychou, M.; Thezenas, S.; Poujol, S.; Pinguet, F.; Thirion, A.; Bleuse, J.; Portales, F.; Samalin, E.; Assenat, E.
Publication
Cancer Chemotherapy & Pharmacology, 2012, Vol 69, Issue 3, p807